“…Specificity of this antibody has been demonstrated by sucrose density gradients and absence of labeling in adsorption controls by immunoprecipitation methods, by preadsorption with the immunizing peptide (Haywood et al, 1999; Quadros et al, 2002; Quadros et al, 2007; Traish & Wotiz, 1990), and in thymus, uterus, and brain of PR knock‐out mice (Kurita et al, 1998; Tibbetts et al, 1999). In particular, nuclear immunoreactivity was completely abolished in all brain regions, including the hippocampus, following preadsorption of the PR peptide with either the antigen peptide (Genosys Biotechnologies, The Woodlands, TX) or a 10‐fold molar excess of human PR‐A and PR‐B proteins (Newell et al, 2018; Quadros et al, 2002). Additionally, immunoreactivity for this antiserum is eliminated in transgenic mice that possess an insertional mutation in the PR gene (i.e., PR knockout mice) (Newell et al, 2018).…”